Evidence map›Paper›PMID 40347278›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

Role of Diabetes and its metabolic pathways in Epilepsy: An insight to various target approaches.

Sakshi Saini, Shital S Panchal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Astrocytic GPR55 receptors promote glycolysis.Journal of cannabis research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sakshi SainiDepartment of Pharmacology, Institute of Pharmacy, Nirma University, S.G Highway, Ahmedabad, 382 481, Gujarat, India.
Shital S PanchalDepartment of Pharmacology, Institute of Pharmacy, Nirma University, S.G Highway, Ahmedabad, 382 481, Gujarat, India. shitalpanchalpharmacology@gmail.com.ORCID http://orcid.org/0000-0003-4211-8202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human brain acts as a crucial organ that requires a high glucose metabolic content. However, abnormal glucose levels act as a major factor for frequent epileptic foci. Thus, it has come to attention in the recent past that epilepsy is a metabolic problem in addition to a neurological condition. However, several studies have postulated a link between epilepsy and diabetes mellitus, but very few have emphasized the exact molecular mechanism behind it and its related specific targets. Hence, this article mainly outlines in-depth knowledge about the molecular mechanisms involved and its associated target approaches. Data from several publications, such as meta-analysis, systematic and narrative reviews, and research papers obtained from electronic databases, have been used for postulating a strong evidence in order to establish a comprehensive article addressing this problem in depth. The data discussed here have revealed how adiponectin levels and mitochondrial activity impact obesity, type 2 diabetes mellitus (T2DM), and epilepsy. We have also tried to give a brief idea about the possible theories that would also impact the severity of these two conditions, including adequate exercise and the impact of commonly used AEDs. Furthermore, one of the factors causing genetic predisposition to seizures due to glucose metabolism, such as GLUT-1 deficiency, has also been described briefly. It has to be mentioned that researchers and clinical practitioners might need to take these factors into account while discovering and evaluating a suitable novel therapeutic in the future.

Indexed as

Diabetes Mellitus, Type 2EpilepsyAnimalsAnticonvulsantsGlucoseHumansMetabolic Networks and PathwaysObesityAnticonvulsantsGlucoseAdiponectin (ADPN)EpilepsyGlucose metabolismGLUT-1 deficiencyMitochondrial dysfunctionNeuronal hyper-excitabilityType 2 diabetes mellitus (T2DM)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.